Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2018) 56 P1142 | DOI: 10.1530/endoabs.56.P1142

ECE2018 Poster Presentations: Thyroid Thyroid cancer (88 abstracts)

Increased incidence of thyroid cancer in a spanish tertiary hospital, valladolid, spain: evolution and clinical characteristics, 2002–2016

Susana Garcia Calvo 1 , Gonzalo Diaz-Soto 1 , Maria Alvarez-Quiñones Sanz 2 , Isabel Martinez-Pino 3 , Beatriz Torres 1 , Juan Jose Lopez 1 , Juan Jose Mateos 2 & Daniel de Luis 1


1Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario de Valladolid, Instituto de Endocrinología y Nutrición, Universidad de Valladolid, Valladolid, Spain; 2Servicio de Anatomía Patológica, Hospital Clínico Universitario de Valladolid, España., Valladolid, Spain; 3Sección Promoción de la Salud. ST Sanidad Valladolid JCYL. CIBERESP-ISCIII, Valladolid, Spain.


Introduction: Thyroid cancer is the most frequent malignant endocrine neoplasia. Its incidence has significantly risen worldwide in the last decades.

Objective: To estimate the incidence of thyroid cancer in Valladolid’s east area population, Spain, over the period 2002–2016.

Methods: A retrospective descriptive research was performed in the Clinical Universitary Hospital of Valladolid (HCUVa). Clinical data was obtained from Anatomical Pathology Registry of HCUVa from 2002 to 2016. At diagnosis, the age, sex, histological features, size and stage of the thyroid tumor were analyzed. Incidence diagnosed rates were calculated adjusted to reference European Population by sex and age in three-year periods.

Results: 398 patients were diagnosed of Differentiated Thyroid Cancer from 2002 to 2016; 78.6% were women with a mean age of 52.44 years (DS 15.20). The overall incidence of thyroid cancer increased over the last 15 years, from 5.2 to 25.7 per 105 population/year in women and from 2.3 to 8.8 per 105 population/year in men (P<0.0001). Incidence rates were significantly higher in males compared to females. Mean age at diagnosis increased from 45.54 years (DS 15.94) to 54.53 years (DS 15.61) (P<0.01). There were no statistical differences in tumor size at diagnosis. However, a size increment trend in papillary macrocarcinomas from 1.8 cm (DS 0.77) to 2.49 cm (DS 1.54) – ns – was observed. Gender and papillary and follicular carcinoma rates kept stable over the period (19.2–21.4%) and (92.3–97.1% and 7.7–3.3%), respectively -ns-. An increase in micropapillary thyroid cancer (<1 cm) from 29.4% to 52.1% -ns- was observed throughout the period. Finally, the distribution of papillary carcinomas over the whole period was: 51.21% of classic variant of papillary thyroid cancer, 42.98% of follicular variant and 5.8% of aggressive variant. An increment of follicular variant and aggressive papillary carcinoma from 29.2% to 50.7% and from 4.2% to 8.2% was observed from 2002 to 2016, respectively (P<0.05).

Conclusions: During the period studied, the incidence of thyroid cancer increased in Valladolid in both sexes. The increase in micropapillary thyroid cancer diagnose was mainly responsible for this rising trend. These results suggest an increase of thyroid cancer in the diagnosis due to changes in clinical practice and the extensive introduction of new diagnostic techniques, such as neck ultrasonography.

Volume 56

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.